Alternative drug to prevent postpartum bleeding could save many lives in low income countries
BMJ 2018; 361 doi: https://doi.org/10.1136/bmj.k2859 (Published 28 June 2018) Cite this as: BMJ 2018;361:k2859- Ingrid Torjesen
- London
A heat stable formulation of carbetocin is as effective as the current standard of care, oxytocin, for preventing excessive bleeding after vaginal birth, a study led by the World Health Organization has shown.1
WHO currently recommends oxytocin as the first choice drug for preventing excessive bleeding after childbirth, but oxytocin must be stored and transported at 2-8°C, which is hard to do in many low and middle income countries. As a result, women giving birth in such countries may not have access to this lifesaving drug or, if they do, it …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.